|
Moderna -23.6%, one day after its surge Moderna (MRNA) closed down -23.6% today after a record surge the previous day, when Merck and Moderna announced a successful large-scale melanoma vaccine trial • The steepest drop among U.S. large caps today; Health Care -1.9%, the worst of the 11 sectors • Bank of America raised its Moderna rating the previous day, citing progress in cancer treatment • Whether the Merck-Moderna melanoma result opens the way to wider cancer vaccines is the next thing to watch Walmart falls -9.2% despite an earnings beat Walmart (WMT) beat on profit, but U.S. comparable-store sales growth fell short of expectations, sending the stock down -9.2% • The second-steepest drop, and the only consumer staples name among the six largest decliners • Meanwhile Alibaba also fell as Q2 profit missed estimates despite strong AI cloud growth, with reported names reacting to the line that missed rather than the strong one • On top of that, Consumer Staples -1.4% and Consumer Discretionary -1.6%, with consumer-facing sectors weak together
|